相关实验视频
Updated: May 30, 2025

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
759
血小板功能缺陷的诊断评估 - 第二部分:关于血小板功能障碍的最新情况
Karina Althaus1,2, Gero Hoepner2,3, Barbara Zieger4
1Medical Faculty of Tübingen, Institute for Clinical and Experimental Transfusion Medicine, Tübingen, Germany.
Hamostaseologie
|January 27, 2025
概括
遗传性血小板功能障碍 (iPFD) 是罕见的,经常被误诊,需要精确的诊断. 了解它们的遗传学,呈现和实验室分析对于有效管理和避免并发症至关重要.
科学领域:
- 血液学 血液学 血液学
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 先天性血小板功能障碍,包括遗传性血小板功能障碍 (iPFD),是影响血小板功能的罕见疾病.
- 这些疾病可以涉及表面受体,血小板颗粒,信号转导或前凝活性,并且经常被误诊,特别是当与血小板缺血相关时.
研究的目的:
- 审查iPFDs的遗传学,临床表现和实验室分析.
- 突出准确诊断对患者管理的重要性,特别是在外科手术前和潜在的异免疫接种的情况下.
主要方法:
- 对iPFDs的现有文献的审查.
- 专注于血小板缺陷的遗传,表型和功能分析.
- 讨论临床影响和诊断挑战.
主要成果:
- 存在变异性出血倾向的iPFDs,可以被误认为是免疫性血小板缺血.
- 血小板受体缺陷 (例如,伯纳德-苏利耶综合征,格兰兹曼血栓硬化) 携带出血和异免疫的风险.
- 血小板颗粒疾病涉及定量/质量缺陷或释放问题,可能会影响信号通路.
结论:
- 通过表型鉴定,功能测定和基因型鉴定对iPFD进行准确的诊断对于适当的患者护理至关重要.
- 了解具体的缺陷对于管理出血风险,外科护理和潜在的并发症,如同免疫接种,至关重要.
- 本次审查强调将遗传和功能数据集成为全面的iPFD评估.
相关概念视频
Structure and Function of Platelets
966
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
966
Formation of the Platelet Plug
4.0K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
4.0K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
462
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
462
Disorders of Hemostasis
690
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
690
Anticoagulant Drugs: Low-Molecular-Weight Heparins
602
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
602
Clot Retraction and Fibrinolysis
3.6K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.6K

